Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2019-08-01 Report Publication Anno…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Update 2019 Annual Calendar of Corporate Events
Report Publication Announcement Classification · 99% confidence The document is very short (2677 characters) and its primary purpose, as indicated by the 'Oggetto' (Subject) and the title 'DIASORIN S.P.A. UPDATE 2019 ANNUAL CALENDAR OF CORPORATE EVENTS', is to announce updates to the schedule of future corporate events, such as Board meetings for results approval. The text explicitly states 'Vedi allegato' (See attachment) and focuses on scheduling rather than presenting detailed financial results or legal outcomes. This structure—a brief announcement about the timing or publication of corporate information—strongly suggests a Report Publication Announcement (RPA). It is not the full report (10-K or IR), nor is it a specific management change (MANG) or dividend notice (DIV).
2019-08-01 English
Aggiornamento Calendario Annuale Eventi Societari 2019
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement (Informazione Regolamentata) from DiaSorin dated August 1, 2019. The subject ('Oggetto') is 'Aggiornamento Calendario Annuale Eventi Societari 2019' (Update to the Annual Calendar of Corporate Events 2019). The text explicitly states 'Vedi allegato' (See attachment) and details future dates for Board meetings and conference calls. Since the document itself is very short and primarily serves to announce an update to the schedule of future corporate events (like results presentations), it fits best as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if the attachment contained a report. Given that it is updating a *calendar* of events rather than publishing a specific financial report or proxy material, RNS is the most appropriate general regulatory category for this type of administrative update that doesn't fit the other specific codes (like DIV, ER, or 10-K). It is not a full report, thus RPA/RNS applies over the specific report types.
2019-08-01 Italian
DIASORIN BOARD OF DIRECTORS APPROVES FIRST HALF 2019 RESULTS. GROWTH IN REVENUES AND PROFITABILITY
Earnings Release Classification · 95% confidence The document is an official announcement from DiaSorin regarding their 'FIRST HALF 2019 RESULTS'. It provides key financial highlights (Revenues, EBITDA, EBIT, Net Profit) and business updates. While it contains financial data, it is structured as a press release/announcement of results rather than a full interim financial report (which would be a much longer, formal regulatory filing). According to the filing definitions, an initial announcement of quarterly/periodical financial results focusing on key highlights is classified as an Earnings Release (ER). H1 2019
2019-07-31 English
DIASORIN: IL CDA APPROVA I RISULTATI DEL 1° SEMESTRE 2019. RICAVI E REDDITIVITÀ IN CRESCITA
Earnings Release Classification · 99% confidence The document is a formal communication from DiaSorin, dated July 31, 2019, announcing that the Board of Directors (CDA) approved the financial results for the 1st Semester of 2019 ("IL CDA APPROVA I RISULTATI DEL 1° SEMESTRE 2019"). It contains detailed financial figures (Revenues, EBITDA, EBIT, Net Income, PFN, Free Cash Flow) for the first half of the year, along with segment breakdowns and guidance confirmation. This structure—a comprehensive report of financial performance for a period shorter than a year (six months)—perfectly matches the definition of an Interim/Quarterly Report (IR). It is not a brief Earnings Release (ER) as it contains extensive detail and tables, nor is it the full Annual Report (10-K). H1 2019
2019-07-31 Italian
Update 2019 Annual Calendar of Corporate Events
Report Publication Announcement Classification · 99% confidence The document is titled 'DIASORIN S.P.A. UPDATE 2019 ANNUAL CALENDAR OF CORPORATE EVENTS'. It lists future dates for key corporate activities, specifically the approval of the Half-Yearly Financial Report and Third Quarter 2019 results. This is an announcement detailing the schedule of future corporate events and reporting deadlines, rather than the report itself or a transcript. Since it is an announcement about future corporate events and reporting schedules, it fits best under the general category of Regulatory Filings (RNS) or potentially a specific announcement type if one were available for 'Calendar Updates'. Given the provided definitions, and since it is a formal regulatory communication ('Informazione Regolamentata') updating the market on the schedule of future corporate actions, RNS (Regulatory Filings) is the most appropriate general classification, as it is not a specific report (like 10-K, IR, ER) but an update about them. However, since it is explicitly updating the calendar of corporate events, and the document is very short and announces future actions, it functions as a general regulatory update.
2019-06-12 English
Aggiornamento Calendario Annuale Eventi Societari 2019
Regulatory Filings Classification · 95% confidence The document is a short communication (2755 characters) from DiaSorin dated June 12, 2019. The subject line is 'Aggiornamento Calendario Annuale Eventi Societari 2019' (Update to the Annual Calendar of Corporate Events 2019). It lists future dates for Board of Directors meetings to approve financial results (Semi-annual and Q3 results). Because the document's primary function is to announce updates to a schedule of future corporate events, and it is very short, it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since it specifically announces the publication/update of corporate event schedules, RPA is a strong candidate, but given the nature of updating a calendar rather than announcing the release of a specific, detailed report (like a 10-K or IR), and considering it's a general corporate update, RNS (Regulatory Filings - the fallback for miscellaneous announcements) is also applicable. However, the content is purely administrative/scheduling regarding future financial reporting dates. Since there is no specific definition for 'Calendar Update', and it is an announcement about corporate events/reporting schedules, RNS is the most appropriate general regulatory filing category if RPA (Report Publication Announcement) is interpreted too narrowly (i.e., only announcing the release of a specific, attached report). Given the context of updating the 'Calendario Annuale Eventi Societari', this is a general regulatory disclosure. I will classify it as RNS as it is a general regulatory announcement that doesn't fit the other specific categories.
2019-06-12 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.